Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Cambrex Corporation    CBM   US1320111073

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
01/20/2015 01/21/2015 01/22/2015 01/23/2015 01/26/2015 Date
21.92(c) 21.94(c) 22.5(c) 22.77(c) 22.51 Last
143 723 185 976 112 782 163 586 119 785 Volume
-1.97% +0.09% +2.55% +1.20% -1.14% Change
More quotes
Company
Cambrex Corp. is a life sciences company that provides products, services and technologies to accelerate and improve the development and commercialization of new and generic therapeutics.It supplies its products and services worldwide to innovator and generic pharmaceutical companies.The company's... 
Sector
Pharmaceuticals
Calendar
02/10Earnings Release
More about the company
Chart CAMBREX CORPORATION
Duration : Period :
Cambrex Corporation Technical Analysis Chart | CBM | US1320111073 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 363 M
EBIT 2014 53,2 M
Net income 2014 37,2 M
Debt 2014 -
Yield 2014 -
Sales 2015 390 M
EBIT 2015 64,5 M
Net income 2015 44,2 M
Debt 2015 -
Yield 2015 -
PER 2014 19,30
PER 2015 16,26
Capi. / Sales 2014 1,94x
Capi. / Sales 2015 1,81x
Capitalization 706 M
More Financials
Latest news on CAMBREX CORPORATION
2014 CAMBREX : To Present At Oppenheimer 25th Annual Healthcare Conference
2014 CAMBREX : Reports Third Quarter 2014 Financial Results
2014 CAMBREX : Reports Third Quarter 2014 Financial Results; Solid third quarter resu..
2014 CAMBREX : posts 3Q profit
2014 CAMBREX : Results of Operations and Financial Condition, Financial Statements an..
2014 CAMBREX : Reports Third Quarter 2014 Financial Results
2014 CAMBREX : to Announce Third Quarter 2014 Financial Results on October 30, 2014
2014 CAMBREX : to Exhibit at the 2014 AAPS Annual Meeting and Exposition
More news
Sector news Pharmaceuticals - NEC
04:13p PFIZER : Commits to Further Reduce Price for Prevenar 13 in the World’s Po..
04:05p GLAXOSMITHKLINE : Major milestone for GSK/NIH candidate Ebola vaccine as first d..
03:24p TEVA PHARMACEUTICAL : Receives FDA Approval for First Generic Nexium® Delayed-Re..
Plus d'actualités du secteur Pharmaceuticals - NEC


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF